Peculiarities of the development and clinical course of fibromyalgia in male individuals

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Fibromyalgia (FM) is a chronic pathology characterized by pain, fatigue, and cognitive impairments. Its clinical course differs in male patients, which is associated with gender stereotypes and differences in pain perception. The aim of this review is to describe FM development in male individuals, identify factors determining the severity of clinical course of the disease, and study the specifics of FM treatment in this patients’ group. The authors searched PubMed and Scopus for scientific articles using keywords fibromyalgia, gender, men, and treatment. Search covered the time period from 1996 to 2024. A total of 47 publications were retrieved from these sources. Significant gender differences in pain perception and affective disorders in case of fibromyalgia were identified. Key aspects of diagnosis and treatment adapted to men with this disease were emphasized. It is important for clinicians to consider gender aspects when diagnosing and treating fibromyalgia. Furthermore, the development of national registries for in-depth analysis of risk factors and clinical manifestations of the disease is also necessary.

全文:

受限制的访问

作者简介

Olga Teplyakova

Ural State Medical University of the Ministry of Healthcare of Russia; Medical association “Novaya bolnitsa” LLC

编辑信件的主要联系方式.
Email: oteplyakova69@gmail.com
ORCID iD: 0000-0003-2114-0419
SPIN 代码: 3208-8679

MD, Dr. Sci. (Medicine), professor of the Department of outpatient therapy, head of the Center of Clinical Rheumatology

俄罗斯联邦, Yekaterinburg; Yekaterinburg

Daria Shalaginova

Ural State Medical University of the Ministry of Healthcare of Russia

Email: dasha.shalaginova@mail.ru
ORCID iD: 0009-0000-1149-143X

resident of the Institute of clinical medicine

俄罗斯联邦, Yekaterinburg

Valeria Pastukhova

Ural State Medical University of the Ministry of Healthcare of Russia

Email: valeriapastuhova28@gmail.com
ORCID iD: 0009-0006-6195-5515

resident of the Institute of clinical medicine

俄罗斯联邦, Yekaterinburg

参考

  1. Favretti M, Iannuccelli C, Di Franco M. Pain biomarkers in fibromyalgia syndrome: Current understanding and future directions. Int J Mol Sci. 2023;24(13):10443. PMID: 37445618. PMCID: PMC10341963. https://doi.org/10.3390/ijms241310443
  2. Qureshi AG, Jha SK, Iskander J, Avanthika C, Jhaveri S, Patel VH et al. Diagnostic challenges and management of fibromyalgia. Cureus. 2021;13(10):e18692. PMID: 34786265. PMCID: PMC8580749. https://doi.org/10.7759/cureus.18692
  3. Hackshaw KV. The search for biomarkers in fibromyalgia. Diagnostics (Basel). 2021;11(2):156. PMID: 33494476. PMCID: PMC7911687. https://doi.org/10.3390/diagnostics11020156
  4. Varrassi G, Rekatsina M, Perrot S, Bouajina E, Paladini A, Coaccioli S et al. Is fibromyalgia a fashionable diagnosis or a medical mystery? Cureus. 2023;15(9):e44852. PMID: 37809234. PMCID: PMC10560069. https://doi.org/10.7759/cureus.44852
  5. Wolfe F. Criteria for fibromyalgia? What is fibromyalgia? Limitations to current concepts of fibromyalgia and fibromyalgia criteria. Clin Exp Rheumatol 2017;35Suppl105(3):3–5. PMID: 28406762.
  6. Gendelman O, Amital H, Bar-On Y, Ben-Ami Shor D, Amital D, Tiosano S et al. Time to diagnosis of fibromyalgia and factors associated with delayed diagnosis in primary care. Best Pract Res Clin Rheumatol. 2018;32(4):489–99. PMID: 31174818. https://doi.org/10.1016/j.berh.2019.01.019
  7. Moshrif A, Mosallam A, Abu-Zaid MH, Gouda W. Evaluating the effect of delayed diagnosis on disease outcome in fibromyalgia: A multi-center cross-sectional study. J Pain Res. 2023;16:1355–65. PMID: 37123049. PMCID: PMC10132293. https://doi.org/10.2147/JPR.S381314
  8. Jiao J, Cheng Z, Wang W, Zhao Y, Jiang Q. Demographic characteristics and clinical features of fibromyalgia in China: A cross-sectional study. Rheumatol Ther. 2021;8(2):817–31. PMID: 33813715. PMCID: PMC8217401. https://doi.org/10.1007/s40744-021-00303-1
  9. The Canadian Institutes of Health Research (CIHR). What is gender? What is sex? URL: https://cihr-irsc.gc.ca/e/47830.html (date of access – 10.09.2025).
  10. Unruh AM. Gender variations in clinical pain experience. Pain. 1996;65(2–3):123–67. PMID: 8826503. https://doi.org/10.1016/0304-3959(95)00214-6
  11. Dao TT, LeResche L. Gender differences in pain. J Orofac Pain. 2000;14(3):169–84; discussion 184–95. PMID: 11203754.
  12. Conversano C, Ciacchini R, Orru G, Bazzichi ML, Gemignani A, Miniati M. Gender differences on psychological factors in fibromyalgia: A systematic review on the male experience. Clin Exp Rheumatol. 2021;39Suppl 130(3):174–85. PMID: 33337987. https://doi.org/10.55563/clinexprheumatol/73g6np
  13. Kokras N, Hodes GE, Bangasser DA, Dalla C. Sex differences in the hypothalamic-pituitary-adrenal axis: An obstacle to antidepressant drug development? Br J Pharmacol. 2019;176(21):4090–106. PMID: 31093959. PMCID: PMC6877794. https://doi.org/10.1111/bph.14710
  14. Martinez-Lavin M. Fibromyalgia in women: Somatisation or stress-evoked, sexdimorphic neuropathic pain? Clin Exp Rheumatol. 2021;39(2):422–25. PMID: 32940205. https://doi.org/10.55563/clinexprheumatol/0c7d6v
  15. Scheff NN, Bhattacharya A, Dowse E, Dang RX, Dolan JC, Wang S et al. Neutrophil-mediated endogenous analgesia contributes to sex differences in oral cancer pain. Front Integr Neurosci. 2018;12:52. PMID: 30405367. PMCID: PMC6204375. https://doi.org/10.3389/fnint.2018.00052
  16. Gregus AM, Levine IS, Eddinger KA, Yaksh TL, Buczynski MW. Sex differences in neuroimmune and glial mechanisms of pain. Pain. 2021;162(8):2186–200. PMID: 34256379. PMCID: PMC8277970. https://doi.org/10.1097/j.pain.0000000000002215
  17. Alexander SN, Green AR, Debner EK, Ramos Freitas LE, Abdelhadi HMK, Szabo-Pardi TA, Burton MD. The influence of sex on neuroimmune communication, pain, and physiology. Biol Sex Differ. 2024;15(1):82. PMID: 39439003. PMCID: PMC11494817. https://doi.org/10.1186/s13293-024-00660-w
  18. Connell RW, Messerschmidt JW. Hegemonic masculinity: Rethinking the concept. Gender & Society. 2005;19(6):829–59. https://doi.org/10.1177/0891243205278639
  19. Ek S. Gender differences in health information behaviour: A Finnish population-based survey. Health Promot Int. 2015;30(3):736–45. PMID: 23985248. https://doi.org/10.1093/heapro/dat063
  20. Katz JD, Mamyrova G, Guzhva O, Furmark L. Gender bias in diagnosing fibromyalgia. Gend Med. 2010;7(1):19–27. PMID: 20189151. https://doi.org/10.1016/j.genm.2010.01.003
  21. Favretti M, Dolcini G, Iannuccelli C, Franculli D, Gioia C, Sarzi-Puttini P et al. Gender differences in the revised Fibromyalgia Impact Questionnaire: A pilot study. Clin Exp Rheumatol. 2023;41(6):1310–16. PMID: 37378485. https://doi.org/10.55563/clinexprheumatol/4mlktj
  22. Sallinen M, Mengshoel AM. “I just want my life back!” – men’s narratives about living with fibromyalgia. Disabil Rehabil. 2019;41(4):422–29. PMID: 29069952. https://doi.org/10.1080/09638288.2017.1395085
  23. Jones GT, Atzeni F, Beasley M, Flub E, Sarzi-Puttini P, Macfarlane GJ. The prevalence of fibromyalgia in the general population: A comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheumatol. 2016;67(2):568–75. PMID: 25323744. https://doi.org/10.1002/art.38905
  24. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Hauser W, Katz RL et al. Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46(3):319–29. PMID: 27916278. https://doi.org/10.1016/j.semarthrit.2016.08.012
  25. Wolfe F, Walitt B, Perrot S, Rasker JJ, Hauser W. Fibromyalgia diagnosis and biased assessment: Sex, prevalence and bias. PLoS One. 2018;13(9):e0203755. PMID: 30212526. PMCID: PMC6136749. https://doi.org/10.1371/journal.pone.0203755
  26. Heidari F, Afshari M, Moosazadeh M. Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis. Rheumatol Int. 2017;37(9):1527–39. PMID: 28447207. https://doi.org/10.1007/s00296-017-3725-2
  27. Miro E, Martinez MP, Sanchez AI, Prados G, Lupianez J. Men and women with fibromyalgia: Relation between attentional function and clinical symptoms. Br J Health Psychol. 2014;20(3):632–47. PMID: 25557603. https://doi.org/10.1111/bjhp.12128
  28. Paulson M, Norberg A, Danielson E. Men living with fibromyalgia-type pain: Experiences as patients in the Swedish health care system. J Adv Nurs. 2002;40(1):87–95. PMID: 12230533. https://doi.org/10.1046/j.1365-2648.2002.02343.x
  29. Теплякова О.В., Морозова А.А. Фибромиалгия: гендерные и возрастные особенности. РМЖ. 2023;(7):32–36. [Teplyakova OV, Morozova AA. Fibromyalgia: Gender and age features. Russkiy meditsinskiy zhurnal = Russian Medical Journal. 2023;(7):32–36 (In Russ.)]. EDN: XWWPIZ.
  30. Iannuccelli C, Lucchino B, Gioia C, Dolcini G, Rabasco J, Venditto T et al. Gender influence on clinical manifestations, depressive symptoms and brain-derived neurotrophic factor (BDNF) serum levels in patients affected by fibromyalgia. Clin Rheumatol. 2022;41(7):2171–78. PMID: 35344113. PMCID: PMC9187562. https://doi.org/10.1007/s10067-022-06133-y
  31. Kueny A, Monteso-Curto P, Lunn S, Mohabbat AB, Clark S, Luedtke C et al. Fibromyalgia pain and fatigue symptoms in Spanish and U.S. men. Pain Manag Nurs. 2021;22(3):423–28. PMID: 33771468. https://doi.org/10.1016/j.pmn.2020.12.003
  32. Ruschak I, Monteso-Curto P, Rossello L, Aguilar Martin C, Sanchez-Monteso L, Toussaint L. Fibromyalgia syndrome pain in men and women: A scoping review. Healthcare (Basel). 2023;11(2):223. PMID: 36673591. PMCID: PMC9859454. https://doi.org/10.3390/healthcare11020223
  33. Sendra A, Farre J. Communicating the experience of chronic pain through social media: Patients’ narrative practices on Instagram. J. Commun. Healthc. 2020;13(1):46–54. https://doi.org/10.1080/17538068.2020.1752982
  34. Sauch Valmana G, Miro Catalina Q, Carrasco-Querol N, Vidal-Alaball J. Gender, mental health and socioeconomic differences in fibromyalgia: A retrospective cohort study using real-world data from Catalonia. Healthcare (Basel). 2023;11(4):530. PMID: 36833067. PMCID: PMC9957461. https://doi.org/10.3390/healthcare11040530
  35. Henao-Perez M, Lopez-Medina DC, Arboleda A, Bedoya Monsalve S, Zea JA. Patients with fibromyalgia, depression, and/or anxiety and sex differences. Am J Mens Health. 2022;16(4):15579883221110351. PMID: 35818673. PMCID: PMC9280828. https://doi.org/10.1177/15579883221110351
  36. Sullivan MJ, Thorn B, Haythornthwaite JA, Keefe F, Martin M, Bradley LA, Lefebvre JC. Theoretical perspectives on the relation between catastrophizing and pain. Clin J Pain. 2001;17(1):52–64. PMID: 11289089. https://doi.org/10.1097/00002508-200103000-00008
  37. Ryum T, Jacobsen HB, Borchgrevink PC, Landro NI, Stiles TC. Interpersonal problems as a predictor of pain catastrophizing in patients with chronic pain. Scand J Pain. 2019;20(1):51–59. PMID: 31560651. https://doi.org/10.1515/sjpain-2019-0064
  38. Thakur ER, Gurtman MB, Keefer L, Brenner DM, Lackner JM; Representing the IBS Outcome Study Research Group. Gender differences in irritable bowel syndrome: The interpersonal connection. Neurogastroenterol Motil. 2015;27(10):1478–86. PMID: 26265427. PMCID: PMC4584187. https://doi.org/10.1111/nmo.12647
  39. Atzeni F, Alciati A, Bazzichi L, Govoni M, Biasi G, Di Franco M et al. Sociodemographic factors in fibromyalgia: Results from the Italian Fibromyalgia Registry. Clin Exp Rheumatol. 2022;40(6):1183–88. PMID: 35748718. https://doi.org/10.55563/clinexprheumatol/64963d
  40. Gove WR, Tudor JF. Adult sex roles and mental illness. AJS. 1973;78(4):812–35. PMID: 4567616. https://doi.org/10.1086/225404
  41. Reich JW, Olmsted ME, van Puymbroeck CM. Illness uncertainty, partner caregiver burden and support, and relationship satisfaction in fibromyalgia and osteoarthritis patients. Arthritis Rheum. 2006;55(1):86–93. PMID: 16463418. https://doi.org/10.1002/art.21700
  42. Braun A, Evdokimov D, Frank J, Pauli P, Uceyler N, Sommer C. Clustering fibromyalgia patients: A combination of psychosocial and somatic factors leads to resilient coping in a subgroup of fibromyalgia patients. PLoS One. 2020;15(12):e0243806. PMID: 33370324. PMCID: PMC7769259. https://doi.org/10.1371/journal.pone.0243806
  43. Blackbeard D, Aldous C. Chronic pain and masculine identity: Life-world interviews with men at a South African Pain Clinic. Int J Qual Stud Health Well-being. 2021;16(1):1970303. PMID: 34435543. PMCID: PMC8405105. https://doi.org/10.1080/17482631.2021.1970303
  44. Flurey C, White A, Rodham K, Kirwan J, Noddings R, Hewlett S. “Everyone assumes a man to be quite strong”: Men, masculinity and rheumatoid arthritis: A case-study approach. Sociol Health Illn. 2018;40(1):115–29. PMID: 29034486. PMCID: PMC5813274. https://doi.org/10.1111/1467-9566.12628
  45. Frackowiak-Sochanska M. Men and social trauma of Covid-19 pandemic. The maladaptiveness of toxic masculinity. Society Register. 2021;5(1):73–94. https://doi.org/10.14746/sr.2021.5.1.04
  46. Ahlsen B, Solbraekke KN. Using narrative perspectives in the clinical setting of physiotherapy. Why and how? In: Gibson BE, Nicholls DA, Setchel J, Groven KS (Eds.). Manipulating practices. A critical physiotherapy reader (pp. 356–377). Oslo, Norway: Cappelen Damm Akademisk. 2018; 384 pp. ISBN 978-82-02-55001-1. https://doi.org/10.23865/noasp.29
  47. Oloruntoba O, Bergeron CD, Zhong L, Merianos AL, Sherman LD, Kew CL et al. Pharmacological prescribing and satisfaction with pain treatment among non-Hispanic black men with chronic pain. Patient Prefer Adherence. 2024;18:187–95. PMID: 38264322. PMCID: PMC10804868. https://doi.org/10.2147/PPA.S435652

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2025